TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biospecialisten Sverige AB
Closing information (x1000 EUR)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
119
|
87
|
108 |
| Financial expenses |
3
|
3
|
1 |
| Earnings before taxes |
8
|
-6
|
-10 |
| EBITDA |
17
|
1
|
-8 |
| Total assets |
38
|
42
|
40 |
| Current assets |
8
|
8
|
11 |
| Current liabilities |
20
|
32
|
23 |
| Equity capital |
18
|
10
|
16 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
47.4%
|
23.8%
|
40.0% |
| Turnover per employee |
119
|
87
|
108 |
| Profit as a percentage of turnover |
6.7%
|
-6.9%
|
-9.3% |
| Return on assets (ROA) |
28.9%
|
-7.1%
|
-22.5% |
| Current ratio |
40.0%
|
25.0%
|
47.8% |
| Return on equity (ROE) |
44.4%
|
-60.0%
|
-62.5% |
| Change turnover |
26
|
-16
|
-67 |
| Change turnover % |
27%
|
-16%
|
-38% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.